In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp…
April 14, 2025 16:05 ET | Source: IRIDEX Corporation MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation…
Believes that Current Board’s Strategic, Management and Capital Allocation Failures have Resulted in Stockholder Value Destruction Highlights Serious Concerns with…
January 31, 2025 09:15 ET | Source: TerrAscend Net Revenue of $74.4 million, up 0.3% from $74.2 million in the…
January 30, 2025 01:30 ET | Source: CLIQ Digital AG CLIQ Digital Reports Preliminary 2024 Results 4Q sales declined q/q…
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast on Monday, January 27, 2025, at 8:00 a.m.…
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast on Monday, January 27, 2025, at 8:00 a.m.…
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast on Monday, January 27, 2025, at 8:00 a.m.…
Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and…
MIAMI, Jan. 18, 2025 /PRNewswire/ -- The Moskowitz Law Firm, PLLC announces the preliminary approval of a proposed class action…
